These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 34931615)

  • 1. Immunological Properties of Exotoxin A Toxoid - Detoxified Lipopolysaccharide - Gold Nanoparticles Conjugate Against Pseudomonas aeruginosa Infection.
    Najafzadeh F; Tanomand A; Haddadi A; Majidi J
    Iran J Immunol; 2021 Dec; 18(4):292-303. PubMed ID: 34931615
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pseudomonas aeruginosa PAO-1 Lipopolysaccharide-Diphtheria Toxoid Conjugate Vaccine: Preparation, Characterization and Immunogenicity.
    Najafzadeh F; Shapouri R; Rahnema M; Rokhsartalab Azar S; Kianmehr A
    Jundishapur J Microbiol; 2015 Jun; 8(6):e17712. PubMed ID: 26301059
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preparation and evaluation of the exotoxin A nano-gold conjugate as a vaccine candidate for
    Abbasi M; Tanomand A; Kafilzadeh F; Zolghadri S; Hosainzadegan H
    Iran J Basic Med Sci; 2021 Oct; 24(10):1366-1372. PubMed ID: 35096294
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunogenicity comparison of conjugate vaccines composed of alginate and lipopolysaccharide of Pseudomonas aeruginosa bound to diphtheria toxoid.
    Najafzadeh F; Jaberi G; Shapouri R; Rahnema M; Karimi-Nik A; Kianmehr A
    Iran J Microbiol; 2014 Oct; 6(5):317-23. PubMed ID: 25848521
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Spectrophotometric, colorimetric and visually detection of Pseudomonas aeruginosa ETA gene based gold nanoparticles DNA probe and endonuclease enzyme.
    Amini B; Kamali M; Salouti M; Yaghmaei P
    Spectrochim Acta A Mol Biomol Spectrosc; 2018 Jun; 199():421-429. PubMed ID: 29649678
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protection against exotoxin A (ETA) and Pseudomonas aeruginosa infection in mice with ETA-specific antipeptide antibodies.
    El-Zaim HS; Chopra AK; Peterson JW; Vasil ML; Heggers JP
    Infect Immun; 1998 Nov; 66(11):5551-4. PubMed ID: 9784572
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pseudomonas aeruginosa polysaccharide-tetanus toxoid conjugate vaccine: safety and immunogenicity in humans.
    Cryz SJ; Sadoff JC; Fürer E; Germanier R
    J Infect Dis; 1986 Oct; 154(4):682-8. PubMed ID: 3091708
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum albumin nanoparticles vaccine provides protection against a lethal Pseudomonas aeruginosa challenge.
    Maria de Souza Morais S; Ferreira Rodigues N; Ingrid Oliveira da Silva N; Aparecido Salvador E; Rodrigues Franco I; Augusto Pires de Souza G; Henrique Cruvinel da Silva P; Gustavo Nogueira de Almeida L; Prado Rocha R; Carolina Toledo da Cunha Pereira A; Portela Ferreira G; Veras Quelemes P; Pereira de Araújo M; Fornias Sperandio F; Júnia de Souza Santos L; Assis Martins Filho O; Cosme Cotta Malaquias L; Felipe Leomil Coelho L
    Vaccine; 2018 Oct; 36(43):6408-6415. PubMed ID: 30228029
    [TBL] [Abstract][Full Text] [Related]  

  • 9. IL-17 is a critical component of vaccine-induced protection against lung infection by lipopolysaccharide-heterologous strains of Pseudomonas aeruginosa.
    Priebe GP; Walsh RL; Cederroth TA; Kamei A; Coutinho-Sledge YS; Goldberg JB; Pier GB
    J Immunol; 2008 Oct; 181(7):4965-75. PubMed ID: 18802100
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protective efficacy of recombinant exotoxin A--flagellin fusion protein against Pseudomonas aeruginosa infection.
    Farajnia S; Peerayeh SN; Tanomand A; Majidi J; Goudarzi G; Naghili B; Rahbarnia L
    Can J Microbiol; 2015 Jan; 61(1):60-4. PubMed ID: 25496361
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protective effect of two new nanovaccines against Pseudomonas aeruginosa based on LPS and OPS: A comparison study.
    Maleki M; Azimi S; Salouti M
    Immunobiology; 2022 Nov; 227(6):152278. PubMed ID: 36115097
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intranasal Peptide-Based FpvA-KLH Conjugate Vaccine Protects Mice From
    Sen-Kilic E; Blackwood CB; Boehm DT; Witt WT; Malkowski AC; Bevere JR; Wong TY; Hall JM; Bradford SD; Varney ME; Damron FH; Barbier M
    Front Immunol; 2019; 10():2497. PubMed ID: 31708925
    [No Abstract]   [Full Text] [Related]  

  • 13. Prophylactic and therapeutic efficacy of immunoglobulin G antibodies to Pseudomonas aeruginosa lipopolysaccharide against murine experimental corneal infection.
    Preston MJ; Gerçeker AA; Koles NL; Pollack M; Pier GB
    Invest Ophthalmol Vis Sci; 1997 Jun; 38(7):1418-25. PubMed ID: 9191605
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protective Potential of Conjugated P. aeruginosa LPS -PLGA Nanoparticles in Mice as a Nanovaccine.
    Safari Zanjani L; Shapoury R; Dezfulian M; Mahdavi M; Shafieeardestani M
    Iran J Immunol; 2020 Mar; 17(1):75-86. PubMed ID: 32224543
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunological evaluation of an alginate-based conjugate as a vaccine candidate against Pseudomonas aeruginosa.
    Farjah A; Owlia P; Siadat SD; Mousavi SF; Ardestani MS; Mohammadpour HK
    APMIS; 2015 Feb; 123(2):175-83. PubMed ID: 25470757
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunoglobulin G antibodies to Pseudomonas aeruginosa lipopolysaccharides and exotoxin A in patients with cystic fibrosis or bacteremia.
    Brauner A; Cryz SJ; Granström M; Hanson HS; Löfstrand L; Strandvik B; Wretlind B
    Eur J Clin Microbiol Infect Dis; 1993 Jun; 12(6):430-6. PubMed ID: 8359163
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serotype-nonspecific protection induced by ribonucleic acid isolated from the ribosomal vaccine of Pseudomonas aeruginosa.
    Gonggrijp R; Mullers WJ; van Boven CP
    Infect Immun; 1981 Jul; 33(1):178-85. PubMed ID: 6167518
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis, characterization and immunological properties of Escherichia coli 0157:H7 lipopolysaccharide- diphtheria toxoid conjugate vaccine.
    Rokhsartalab-Azar S; Shapouri R; Rahnema M; Najafzadeh F; Kianmehr A
    Iran J Microbiol; 2015 Jun; 7(3):150-5. PubMed ID: 26668702
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biosynthesis of gold nanoparticles using Pseudomonas aeruginosa.
    Husseiny MI; El-Aziz MA; Badr Y; Mahmoud MA
    Spectrochim Acta A Mol Biomol Spectrosc; 2007 Jul; 67(3-4):1003-6. PubMed ID: 17084659
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of a purified outer membrane protein F (porin) preparation of Pseudomonas aeruginosa as a protective vaccine in mice.
    Gilleland HE; Parker MG; Matthews JM; Berg RD
    Infect Immun; 1984 Apr; 44(1):49-54. PubMed ID: 6323316
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.